CORD-19:e847d433e7424152a9846673209cb73027415ecd / 347001-347215 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3194","span":{"begin":0,"end":214},"obj":"Sentence"},{"id":"T61666","span":{"begin":0,"end":214},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"At the end of this observation period, a mean reduction of serum triglyceride levels of 21.7% (range 14.6-30.4%), and 30.1% for cholesterol (range 18.5-35.4% was achieved, compared with baseline values; p \u003c 00.01)."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T61","span":{"begin":0,"end":214},"obj":"Sentence"}],"text":"At the end of this observation period, a mean reduction of serum triglyceride levels of 21.7% (range 14.6-30.4%), and 30.1% for cholesterol (range 18.5-35.4% was achieved, compared with baseline values; p \u003c 00.01)."}

    CORD-19-PD-UBERON

    {"project":"CORD-19-PD-UBERON","denotations":[{"id":"T248","span":{"begin":59,"end":64},"obj":"Body_part"}],"attributes":[{"id":"A248","pred":"uberon_id","subj":"T248","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"At the end of this observation period, a mean reduction of serum triglyceride levels of 21.7% (range 14.6-30.4%), and 30.1% for cholesterol (range 18.5-35.4% was achieved, compared with baseline values; p \u003c 00.01)."}